G-Shock’s new watch may revisit its oldest design from the 1980s. But the technique used for its unique bezel and bracelet actually dates back more than a millennium. Tsuiki, believed to have ...

Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

“How do they do that?” is a reasonable response to certain things we see in nature. Pythons and snakes like them can eat prey as big as they are, sometimes even bigger, and digest their massive single ...

The NCAA has been a bit of a mess as of late. Between players getting popped for sports betting scandals and guys in their mid-20s eschewing both the professional ranks and the workforce to stay in ...

At the NAB Show in Las Vegas last month, Pearl TV, the consortium of broadcasters, manufacturers and industry advocates showcased prototypes of new converter boxes that would allow consumers to ...

"Ozempic face," "Ozempic butt," "Ozempic breath," even "Ozempic feet" — as those using GLP-1 medications for weight loss probably already know, people can be tough on them, even with the skyrocketing ...

NASHVILLE, Tenn. (WSMV) - Tennessee lawmakers have passed a bill that would require sheriffs of each county to enter an agreement under an available federal 287(g) immigration enforcement program by ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at streamlining access to weight loss drugs, ...